Physician
LA Joya's Neighborhood Doctor, P.A.
LA Joya's Neighborhood Doctor, P.A. was paid $568K by Medicaid between Jan 2018 and Dec 2024, across 114 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoLA JOYA'S NEIGHBORHOOD DOCTOR, P.A.
MISSION, TX 78572
MISSION, TX 78572
33aNPI1740301985assigned 04/03/2007
33bProvider typeFamily Medicine Physician
28Total paid$568K
24GClaims191,051
24DCodes billed114
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#159 of 1,204
Median peer was paid$31K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,065 | $87K | |
| 2019 | 15,292 | $73K | |
| 2020 | 30,267 | $79K | |
| 2021 | 42,240 | $130K | |
| 2022 | 35,741 | $103K | |
| 2023 | 33,043 | $37K | |
| 2024incomplete | 17,403 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 8,149 | 6,355 | $181K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 5,839 | 4,595 | $140K |
| 99444 | 22% | 2,209 | 580 | $126K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.1% | 2,867 | 1,953 | $18K |
| 99441 | 2.5% | 1,086 | 916 | $14K | |
| 86769 | 2.1% | 450 | 185 | $12K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 3,884 | 3,236 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 914 | 414 | $8K |
| 99000 | 1.0% | 989 | 844 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.0% | 354 | 293 | $6K |
| 99423 | <1% | 508 | 38 | $5K | |
| 71047 | <1% | 205 | 181 | $4K |
102 more codes
| 93000 | <1% | 579 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,297 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 907 | $3K |
| 82948 | <1% | 4,258 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 73 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 46 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 242 | $2K |
| 99490 | Ccm add 20min | <1% | 960 | $2K |
| 81003 | <1% | 2,944 | $2K | |
| 99422 | <1% | 92 | $2K | |
| 87650 | <1% | 213 | $2K | |
| 99421 | <1% | 81 | $1K | |
| 99051 | <1% | 1,518 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 19 | $989.72 |
| 99050 | <1% | 90 | $867.66 | |
| 85027 | <1% | 269 | $836.22 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 55 | $813.66 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 18 | $709.24 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 598 | $630.15 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 148 | $456.22 |
| 99442 | <1% | 17 | $427.89 | |
| 74018 | <1% | 18 | $360.59 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 389 | $302.34 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 629 | $247.10 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 128 | $233.00 |
| 92552 | <1% | 34 | $227.34 | |
| 81002 | <1% | 195 | $170.25 | |
| 92250 | <1% | 14 | $155.40 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 391 | $139.11 |
| 90756 | <1% | 147 | $93.91 | |
| 93923 | <1% | 30 | $42.94 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,558 | $18.90 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 688 | $14.55 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 58 | $13.20 |
| 99173 | <1% | 61 | $3.60 | |
| 1000F | 0% | 929 | $0.00 | |
| 1126F | 0% | 7,581 | $0.00 | |
| 3074F | 0% | 7,257 | $0.00 | |
| 4086F | 0% | 623 | $0.00 | |
| 1036F | 0% | 10,993 | $0.00 | |
| 1125F | 0% | 2,746 | $0.00 | |
| 2000F | 0% | 7,914 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 8,818 | $0.00 |
| 3044F | 0% | 255 | $0.00 | |
| 2010F | 0% | 9,977 | $0.00 | |
| 1101F | 0% | 606 | $0.00 | |
| 3079F | 0% | 2,247 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 3,227 | $0.00 |
| 99070 | 0% | 556 | $0.00 | |
| 3008F | 0% | 8,911 | $0.00 | |
| 2001F | 0% | 8,975 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 1,790 | $0.00 |
| 3075F | 0% | 268 | $0.00 | |
| 36416 | 0% | 205 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 451 | $0.00 |
| 1170F | 0% | 111 | $0.00 | |
| 82962 | 0% | 81 | $0.00 | |
| 4050F | 0% | 155 | $0.00 | |
| 1220F | 0% | 13 | $0.00 | |
| 1111F | 0% | 54 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 118 | $0.00 |
| 4010F | 0% | 20 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 18 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 12 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 17 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 6,788 | $0.00 |
| 1159F | 0% | 4,842 | $0.00 | |
| 99401 | 0% | 487 | $0.00 | |
| G0247 | Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails | 0% | 399 | $0.00 |
| 1026F | 0% | 161 | $0.00 | |
| 2014F | 0% | 929 | $0.00 | |
| 3288F | 0% | 1,347 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 7,635 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 932 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 1,898 | $0.00 |
| 1160F | 0% | 1,370 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 8,462 | $0.00 |
| 1003F | 0% | 6,780 | $0.00 | |
| G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 239 | $0.00 |
| 3078F | 0% | 5,541 | $0.00 | |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education | 0% | 233 | $0.00 |
| 0518F | 0% | 740 | $0.00 | |
| 0521F | 0% | 2,330 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 270 | $0.00 |
| 3725F | 0% | 65 | $0.00 | |
| 3077F | 0% | 219 | $0.00 | |
| 4158F | 0% | 15 | $0.00 | |
| G9781 | Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons) | 0% | 378 | $0.00 |
| 1033F | 0% | 2,097 | $0.00 | |
| 3006F | 0% | 52 | $0.00 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 645 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 221 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 59 | $0.00 |
| 2028F | 0% | 52 | $0.00 | |
| 4013F | 0% | 138 | $0.00 | |
| 4004F | 0% | 22 | $0.00 | |
| 3210F | 0% | 413 | $0.00 | |
| 99499 | 0% | 50 | $0.00 | |
| 4040F | 0% | 31 | $0.00 | |
| 99071 | 0% | 15 | $0.00 | |
| 2022F | 0% | 13 | $0.00 | |
| G8451 | Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons) | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSALAS, HECTOR (ADMINISTRATOR)